Permanently Discontinued

APO-IPRAVENT STERULES

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO-IPRAVENT STERULES discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO-IPRAVENT STERULES 0.025% has been permanently discontinued (last updated October 5, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO-IPRAVENT STERULES not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file5 products · 2 same form & route

Affected strength0.025%

Report last updated2017-10-05

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

TEVA-IPRATROPIUM STERINEBS

TEVA CANADA LIMITED

250MCG · DIN 02216221

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-IPRATROPIUM

PHARMASCIENCE INC

250MCG · DIN 02231245

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

ATROVENT HFA

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

20MCG · DIN 02247686

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

JAMP IPRATROPIUM HFA

JAMP PHARMA CORPORATION

20MCG · DIN 02542587

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

IPRAVENT

AA PHARMA INC

42MCG · DIN 02246084

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02231494

Strength

0.025%

Dosage Form

SOLUTION

Route

INHALATION

Active Ingredient

IPRATROPIUM BROMIDE

See all IPRATROPIUM BROMIDE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2017-10-05

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244